ABSTRACT
InTRoduCTIon
Despite many alternatives of antiepileptic drugs, up to 30 % of patients with epilepsy will suffer poor seizure control from maximal therapy. (7) Approximately 60 % of these patients are candidates for resective surgery. (14) Patients who are not suitable for resective surgery, vagus nerve stimulation, a form of neuromodulation therapy, may provide additional benefit in combination with medical treatment that is greater than 50% reduction in seizure frequency. (3) Another form of neuromodulation is deep brain stimulation. The significant experience of DBS in movement disorders in view of its advantages such as titratability, reversibility and safety led researchers to investigate its use in epilepsy treatment. In selected patients, DBS of several targets in the central nervous system, such as caudate nucleus, anterior nucleus of the thalamus, cerebellum, hippocampus and subthalamic nucleus resulted in seizure reduction. (6, 13, 15) Although the underlying mechanism of action of DBS is obscure, some evidence suggests that the most likely mechanism may involve stimulation induced modulation of the pathological neural networks. (8, 10) Inhibition of the neurons immediately adjacent to the stimulation area is probably involved. The applied current may inhibit neurons with a pathologically lowered threshold of activation. Alternatively, DBS may act on neural network projections to nearby or remote CNS structures originating from the area of stimulation.
Different stimulation parameters are investigated in experimental models of epilepsy. Epileptic activity is suppressed effectively with subthalamic nucleus DBS in rats with over 130Hz. (16) Stimulation of anterior nucleus of thalamus with 100 Hz in pentylentetrazole model of epilepsy in rats inhibited clinical seizures. (11) The results of therapeutic DBS to stop seizures varies according to the stimulation site and frequency applied. Amygdala and pyriform cortex kindled seizures are suppressed with slow (1Hz) stimulation, however tuberomamillary DBS facilitated epileptic seizures with high frequencies (60-100 Hz). (2, 5, 20) The optimal treatment parameters are not clearly defined. Generally the parameters that are used for movement disorders are applied in the treatment of epilepsy with DBS.
In this study, the aim was to determine the effects of high frequency (185Hz) hippocampal DBS with gradual increments of stimulus intensity on cortical epileptic discharges in a penicillin-induced epilepsy model in rats.
MATERIAL and METHodS
Twenty-five adult female Sprague-Dawley rats (175 gr mean body weight) were enrolled in the study maintained under standard laboratory conditions (temperature 22 °C; light/ dark cycle 12/12h; ad libitum availability of pellet food and water). Animal care ad all experimental procedures were in accordance with those detailed in NIH Guide for the Use and Care of Laboratory Animals. The animals were fully anesthetized with a combination of xylazine (10mg/kg) and ketamine (90mg/kg) intra-peritoneally. This study was approved by the local ethics committee.
Electrode implantation and penicillin-G induced epilepsy model
All of the animals were implanted hippocampal deep electrodes for stimulation with stereotactic methods. Under general anesthesia, the animals were placed in the stereotactic framer (Stoelting, UK) and a Teflon insulated stainless steel bipolar electrode was implanted to the right hippocampus via an occipital burr hole. The coordinates were 4,5mm posterior and 3 mm lateral to bregma and 3mm vertical from dura according to Paxinos and Watson's stereotactic atlas. (12) The rats were randomly allocated to two groups; experiment group (EG) (500IU penicillin-G in a volume of 8 µl injected intracortically, n=20) and control group (CG) (8µl saline injected intracortically, n=5). Penicillin-G or saline was injected to right primary motor cortex intracortically via stereotactic frame (coordinates: 0,7mm anterior and 2mm lateral to bregma and 2mm vertical from dura according to Paxinos and Watson's stereotactic atlas. (12) Following penicillin-G injection the EG was further allocated to two groups: EG-1 (hipocampal DBS off, n=10) and EG-2 (hippocampal DBS on; pulse stimulus (5,35msec duration) with 10 min intervals, output current (OC): 0,5 V, 1V, 2V and 5V for 60 seconds, n=10).
EEG Analysis
The epileptic activity was recorded and analyzed by Power lab system (Power Lab UK, 2000) before and after the hippocampal electrode implantation and penicillin-G injection. The recording parameters were as follows: 0,3-50 Hz low and high frequency filter, 50Hz notch filter, recording speed 30cm/sec.
Thirty second recordings free from artifacts were selected as the samples of spike/cortical activity and reaction to increasing stimulus intensities, at 15th minute after penicillin-G injection and 10th minute following each stimulus (0,5V, 1V, 2V, and 5V).
The EEG signals obtained from these samples were analyzed according to frequency and amplitude. In addition to this, the power spectrum analysis was performed by fast Fourier transformation (software, Chart ™5.2.2, eDAQ).
Statistical Analysis
In the statistical analysis, the paired samples t-test was used for related samples and Mann-Whitney-U and Friedman's twoway analysis of variance was applied for unrelated samples. P values smaller than 0.05 were statistically significant. The power spectrums were analyzed by one way ANOVA test and Tukey test was applied for post-hoc analysis (SPSS 16.0 version).
RESuLTS
The first epileptic discharges were observed in 3-7 minutes following penicillin-G injection and reached their maximum in approximately 15 minutes. The EEG recording lasted 60 minutes. (Figure 1-3 ) In the EG-1, spike frequency was maintained at high levels throughout the experiment; however in EG-2 spike frequency was significantly reduced at each stimulus intensity (p<0,005). (Figure 4) On the other the amplitudes did not change following the hippocampal stimulation.
The power spectrum analysis revealed that all of the stimulus intensities promoted significant reduction in cortical spike activity (p=0,0001). (Figure 5 ) Following 5V hippocampal stimulus, the EEG activity was similar to those before the experiment. In EG-1, the significant increase in power spectrum was maintained all through the experiment. ( Figure  5 )
In the control group neither saline injection nor hippocampal stimulation caused epileptic discharges and seizures. However, following 5 V hippocampal stimulus a diffuse slowing in the cerebral bioelectrical activity was observed.
dISCuSSIon
The neurostimulation therapies for epilepsy use primarily electrical stimuli of varying frequencies to impede epileptic activity. A variety of sites are approached to treat epilepsy, such as cerebellum, subthalamic nucleus, caudate nucleus, thalamus and hippocampus. These structures are either a part of the Papez circuit or have connections with it. Considering the role of Papez circuit in generation and propagation of the epileptic activity, interrupting the circuit can potentially prevent the generation and propagation of clinical and subclinical seizures with a well-tuned stimulation. Although the exact mechanism of neuromodulation is still obscure, the therapeutic stimulus can inactivate neurons by blocking depolarization and reducing the recruitment of the neurons in terms of the rhythmic epileptic activity they induce. (9) Moreover, neural stimulation can activate the inhibiting neurons and their projections, thus result in antiepileptic effect by changing the properties of the networks. (9) However, the significance of each of these mechanisms for the efficacy of therapeutic stimulation depends critically on the targeted region and on the stimulus parameters.
The experimental and clinical studies focusing on stimulation of some target regions such as subthalamic nucleus, caudate nucleus and cerebellum did not display satisfactory results in terms of seizure control. (9) However, the stimulation of anterior nucleus of thalamus, a relay station of the limbic system in close relation with both hippocampi and neocortex, can have an effect both on the epileptogenic focus and further spread of the epileptic activity. In a large controlled prospective multicenter study (SANTE), a significant reduction of seizure control was achieved in 54% of the patients. This safe and tolerable method of treatment is recommended in some patients with medically refractory partial and secondarily generalized seizures. (4) Another rational target for epilepsy is the hippocampus considering the prevalence of mesial temporal lobe epilepsy (MTLE). In kindled rats, continuous 130 Hz stimulation of the hippocampus led to significant reduction in the excitability of the hippocampus. (21) Furthermore, high frequency stimulation at 130 Hz found to be more effective than low frequency in reducing the hippocampal excitability in epileptic rats. Admittedly the optimal stimulation parameters for treatment of epilepsy with hippocampal stimulation are not clearly defined and there is a trend to use similar stimulation parameters as used for the movement disorders. Another general opinion about DBS for epilepsy is that the clinical benefit would be obvious not as rapid as it is seen in movement disorders. By contrast, our study revealed that hippocampal stimulation with high frequencies (185 Hz) can effectively suppress the acute cortical epileptic discharges independent from the stimulus intensity. Moreover, the high frequency hippocampal stimulation did not promote epileptic discharges in non-epileptic control group. Hippocampal DBS seems to a safe and tolerable method of treatment in epilepsy, but the optimal stimulation parameters that are frequency, output current and stimulus duration are not clearly defined. Therefore, the results of this study are important in helping to set the parameters in patients with epilepsy treated with hippocampal DBS. In addition, the particularly acute spike suppressing effect of high frequency hippocampal DBS on remote seizure focus may help designing further studies focusing to clarify the exact mechanism behind the clinical benefits of this treatment.
Nevermore, further studies are required to determine whether the stimulus should target the origin of the seizure or subcortical structures, and whether the best seizure control can be achieved with open-loop stimulus or closedloop stimulus. 
